Elucidation of selection mechanism of disseminated cancer cells in metastatic organs
Project/Area Number |
26462064
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Kyushu University |
Principal Investigator |
ONIMARU Manabu 九州大学, 医学研究院, 共同研究員 (80529876)
|
Co-Investigator(Kenkyū-buntansha) |
江上 拓哉 九州大学, 医学研究院, 共同研究員 (40507787)
真鍋 達也 九州大学, 大学病院, 講師 (60546464)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 膵癌 / 肝転移 / CD110 / トロンボポエチン(TPO) / ERK / MYC / 癌幹細胞 / トロンボポエチン |
Outline of Final Research Achievements |
To elucidate the mechanism of liver metastasis of pancreatic cancer, we focused on thrombopoietin (TPO) and its receptor CD 110 in pancreatic cancer. In resected specimens of pancreatic cancer, high expression of CD110 was an independent poor prognostic factor and independent predictor of liver metastasis. Inhibition of CD110 expression in pancreatic cancer cells significantly reduced migration / invasion ability of pancreatic cancer cells. In CD110-positive pancreatic cancer cells, ERK and MYC were activated by TPO administration, and cell proliferation was increased. These results suggested that TPO - CD110 - ERK - MYC signal might be involved in liver metastasis in pancreatic cancer.
|
Report
(4 results)
Research Products
(9 results)
-
[Journal Article] Suppression of CD51 in pancreatic stellate cells inhibits tumor growth by reducing stroma and altering tumor-stromal interaction in pancreatic cancer2016
Author(s)
Horioka K, Ohuchida K, Sada M, Zheng B, Moriyama T, Fujita H, Manabe T, Ohtsuka T, Shimamoto M, Miyazaki T, Mizumoto K, Oda Y, Nakamura M.
-
Journal Title
Int J Oncol
Volume: 48
Issue: 4
Pages: 1499-1508
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL.2016
Author(s)
Chijiiwa Y, Moriyama T, Ohuchida K, Nabae T, Ohtsuka T, Miyasaka Y, Fujita H, Maeyama R, Manabe T, Abe A, Mizuuchi Y, Oda Y, Mizumoto K, Nakamura M
-
Journal Title
Int J Oncol
Volume: 48
Issue: 4
Pages: 1688-1700
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells2015
Author(s)
Zheng B, Ohuchida K, Cui L, Zhao M, Shindo K, Fujiwara K, Manabe T, Torata N, Moriyama T, Miyasaka Y, Ohtsuka T, Takahata S, Mizumoto K, Oda Y, Tanaka M
-
Journal Title
Int J Oncol.
Volume: 47
Issue: 2
Pages: 490-498
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-